Asger Bihlet is currently serving as the Chief Scientific Officer at Sanos Group A/S and NBCD A/S. With a background in pharmaceutical sciences, Asger has held various medical and regulatory roles at companies such as Nordic Bioscience A/S, sanofi-aventis, and Ferring. Asger is also pursuing a Doctor of Philosophy degree in Osteoarthritis Clinical Trial Design at the University of Southern Denmark.
Sign up to view 0 direct reports
Get started